This is almost always telogen effluvium, a stress-related hair shedding triggered by rapid metabolic change, caloric deficit, or protein inadequacy rather than the medication itself
Initially, incretin therapies focused on synthesizing GLP-1 analogues that were resistant to degradation by dipeptidyl peptidase-4 (DPP-4), which rapidly breaks down endogenous GLP-1 (Rhrborn et al., 2015)
*Includes gastroparesis, cholecystitis, cholelithiasis, bowel obstruction, cyclic vomiting, syndrome, gastroenteritis, and pancreatitis
4ae) may help guide the use of a SGLT2i + DPP4i combination in clinical practice
You still receive the same amount of medication over seven days
Certain foods can naturally trigger the release of this hormone as part of normal digestion